Skip to main content
. 2021 Apr 8;11:7721. doi: 10.1038/s41598-021-87023-2

Table 9.

Treatment group designations and treatments by period.

Group and treatment sequence 2-week baseline period (non-blinded) 3-week treatment period 1 (T1a) 3-week treatment period 2 (T2a)
1 (PP) Placebo Placebo Placebo
2 (RR) Placebo Robenacoxib Robenacoxib
3 (RP) Placebo Robenacoxib Placebo

P placebo, R robenacoxib.

aTreatment periods T1 and T2 were blinded.